Form 4: Lexicon Pharmaceuticals VP Wendy McDermott Reports Stock Transactions
SEC Form 4 Filing
Wendy McDermott, VP of Human Resources at Lexicon Pharmaceuticals, reported the vesting and subsequent disposal of restricted stock units to cover tax obligations on February 28, 2024.
Summary
- On February 28, 2024, Wendy McDermott, VP of Human Resources at Lexicon Pharmaceuticals, exercised restricted stock units.
- A total of 18,944 and 27,697 restricted stock units vested and were converted into common stock.
- 22,425 shares were withheld by the company to satisfy tax obligations at a price of $2.62 per share.
- Following these transactions, McDermott directly owns 52,694 shares of Lexicon Pharmaceuticals common stock and 18,943 and 55,393 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing reflecting standard insider transactions related to stock-based compensation. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of transaction: vesting of restricted stock units and subsequent disposal of shares for tax obligations. |
| 02/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.